> Caraco Pharmaceutical Laboratories got the FDA's tentative approval to sell a chewable form of the allergy med Zyrtec, whose patent expires in December. Release [1]
> Critical Therapeutics has launched an inhalation treatment for chronic obstructive pulmonary disease. Report [2]
> Beijing Med-Pharm is expanding its senior management team with a new vice president Yanping Zhao, who will oversee all the company's Chinese subsidiaries and handle corporate strategy such as mergers and acquisitions. Report [3]
> Coley Pharmaceutical Group has adopted a shareholder rights plan to protect itself from hostile takeover, saying the plan wasn't prompted by any current takeover attempt. Release [4]
> Jazz Pharmaceuticals added Kohlberg Kravis Roberts & Co. Principal Nathaniel Zilkha to its board. Release [5]
And Finally... What's in a drug name? Oh, $200,000 to $500,000 in consulting costs. Report [6]
Links:
[1] http://www.fiercebiotech.com/press-releases/press-release-caraco-pharmaceutical-laboratories-announces-tentative-fda-approval-g-0
[2] http://boston.bizjournals.com/boston/stories/2007/10/08/daily2.html?jst=b_ln_hl
[3] http://philadelphia.dbusinessnews.com/shownews.php?newsid=135985&type_news=latest
[4] http://www.fiercebiotech.com/press-releases/press-release-coley-pharmaceutical-group-adopts-shareholder-rights-plan
[5] http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=ind_focus.story&STORY=/www/story/10-08-2007/0004677509&EDATE=MON+Oct+08+2007,+08:30+AM
[6] http://www.usatoday.com/money/industries/health/2007-10-07-drug-names_N.htm